Read the reviews on Health equity, care access and quality in headache- Part 1 and Part 2 here!
Featured Articles: July, 2024
Celebrating 25 years of The Journal of Headache and Pain
This year marks the 25th anniversary of The Journal of Headache and Pain! We are celebrating the journal's success over the past 25 years and recognising the contributions of scientists from around the world who have made the journal into what it is today.
Call for papers
AI Advancements in Headache Research: Navigating the Digital Frontier
Edited by: Gianluca Coppola and Igor Petrušić
This collection explores the use of machine learning in migraine research, focusing on advanced algorithms and computational techniques to analyze clinical and neuroimaging data, aiming to uncover patterns and relationships with digital twin solutions.
Endogenous Treatments for Migraine Pain
Edited by: Adriana Della Pietra and Andrew Russo
This collection aims to provide a better understanding of the basic molecular mechanisms of endogenous pain management. This may lead to better and/or alternative migraine pain treatments based on an enhancement of endogenous analgesic systems.
Headache Burden in Children and Adolescents
Edited by: Marco Antônio Arruda and Timothy J. Steiner
This series will embrace estimates from worldwide of headache-attributed burden, studies characterising the headache disorders of childhood and their evolution throughout adolescence (especially longitudinal cohort studies), those providing insights into the diagnostic uncertainties of child and adolescent headache, and those proposing or evaluating systems of care for child and adolescent headache.
Spreading Depolarization in Headache Disorders
Edited by: Shih Pin Chen and Cenk Ayata
This new collection in The Journal of Headache and Pain invites researchers, clinicians, and academicians to discuss spreading depolarization, exploring its mechanisms, relevance, and implications in both primary and secondary neurological disorders.
Vascular Triggers of Headache Disorders
Edited by: Shih Pin Chen and Cenk Ayata
The Journal of Headache and Pain invites submissions on the interplay between vascular mechanisms and headache, particularly migraine, to our new Collection: Vascular Triggers of Headache.
Gender-Specific Aspects of Headache
Edited by: Antoinette Maassen van den Brink and Bianca Raffaelli
The Journal of Headache and Pain is calling for submissions to our Collection on Gender-Specific Aspects of Headache. This collection aims to explore the multifaceted relationship between gender (as well as biological sex) and headache, encompassing both biological and socio-cultural dimensions.
Article collections
Click here to see the article collections and thematic series that the journal has published in recent years.
From the Junior Editorial Board
Exploring SDG3: Good Health and Wellbeing
Collaborative evidence-based approaches to public policy and healthcare policy and practice are essential, not only in addressing inequalities but also in building trusted sustainable ways forward in which to ensure good health and wellbeing for all. The Journal of Headache and Pain supports submissions that address the SDG3 targets and indicators.
Read MoreVisual Abstracts
The Journal of Headache and Pain encourages authors to submit a visual abstract as a supplementary file along with their manuscripts.
As an author submitting at The Journal of Headache and Pain you are entitled to a 20% discount on professionally produced visual abstracts. Click here to find out more about the service, and your discount will be automatically applied when using this link.
Read MoreAims and scope
The Journal of Headache and Pain is a peer-reviewed open access journal specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data. With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine. Read more.
Partnering with the Asian Regional Consortium for Headache (ARCH)
We are delighted to welcome the Asian Regional Consortium for Headache (ARCH) as a partner of The Journal of Headache and Pain. ARCH joins the European Headache Federation and Lifting The Burden in affiliating with the journal. Read more about this partnership here.
Articles
-
-
Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics
-
Ventral posteromedial nucleus of the thalamus gates the spread of trigeminal neuropathic pain
-
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile
-
Occipital nerve stimulation for cluster headache: lessons to learn from the ‘voltage tuners’
Top cited articles 2021-2022
Review article | 12 April 2022
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates December 2020
Lars Jacob Stovner, Knut Hagen, Mattias Linde & Timothy J. Steiner
Consensus article | 11 June 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention-2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, Lars Bendtsen, Christina I. Deligianni, Raquel Gil-Gouveia, Zaza Katsarava, Antoinette MaassenVanDenBrink, Paolo Martelletti, Dimos-Dimitrios Mitsikostas, Raffaele Ornello, Uwe Reuter, Margarita Sanchez-del-Rio, Alexandra J. Sinclair, Gisela Terwindt, Derya Uluduz, Jan Versijpt & Christian Lampl
Review article | 10 June 2021
Migraine and neuroinflammation: the inflammasome perspective
Oguzhan Kursun, Muge Yemisci, Arn M. J. M. van den Maagdenberg & Hulya Karatas
Research article | 3 May 2021
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Giulia Pierangeli, Carlo Lovati, Marco Aguggia, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Renata Rao, Francesco Bono, Angelo Ranieri, Maria Albanese, Sabina Cevoli & Piero Barbanti for the GARLIT Study Group
Review article | 14 July 2021
Comorbidities of primary headache disorders: a literature review with meta-analysis
Valeria Caponnetto, Manuela Deodato, Micaela Robotti, Maria Koutsokera, Valeria Pozzilli, Cristina Galati, Giovanna Nocera, Eleonora De Matteis, Gioacchino De Vanna, Emanuela Fellini, Gleni Halili, Daniele Martinelli, Gabriele Nalli, Serena Serratore, Irene Tramacere, Paolo Martelletti & Alberto Raggi On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Research article | 25 October 2021
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Fenne Vandervorst, Laura Van Deun, Annelies Van Dycke, Koen Paemeleire, Uwe Reuter, Jean Schoenen & Jan Versijpt
Review article | 1 August 2022
Long COVID headache
Claudio Tana, Enrico Bentivegna, Soo-Jin Cho, Andrea M. Harriott, David GarcÃa-AzorÃn, Alejandro Labastida-Ramirez, Raffaele Ornello, Bianca Raffaelli, EloÃsa Rubio Beltrán, Ruth Ruscheweyh & Paolo Martelletti
Research article | 21 April 2021
Disability, quality of life, productivity impairment and employer costs of migraine in the workplace
Toshihiko Shimizu, Fumihiko Sakai, Hitoshi Miyake, Tomofumi Sone, Mitsuhiro Sato, Satoshi Tanabe, Yasuhiro Azuma & David W. Dodick
Short Report | 7 October 2021
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
Edoardo Caronna, Victor José Gallardo, Alicia Alpuente, Marta Torres-Ferrus & Patricia Pozo-Rosich
Research article | 3 January 2022
IL-17 crosses the blood-brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine
Hao Chen, Xueqian Tang, Jin Li, Bangyan Hu, Wenqin Yang, Meng Zhan, Tengyun Ma & Shijun Xu
Publication years: 2021-2022
Source: Web of Science, data collected: January 2024
Trending articles
Click here to view which articles were talked about the most last month!
Editorial Board spotlight
Lanfranco Pellesi, PhD. is a clinical pharmacologist, and Assistant professor at the University of Southern Denmark. He recently obtained his Ph.D. under the supervision of Prof. Ashina investigating the effects of a 2-hour infusion of VIP in healthy volunteers and individuals with migraine without aura. His own research programme aims at elucidating the mechanisms of primary headaches and medication overuse headache through clinical and basic science studies. He spends the rest of his working time leading Pharmacology teaching for medical and pharmaceutical students.
From the Editors
Analysis of a Success Story (2008-2024)
In this blog, Prof. Paolo Martelletti, Editor-in-Chief, discusses the recently announced 2023 Journal Citation Reports (JCR) from Clarivate, with regards to The Journal of Headache and Pain.
Behind the Paper
In this blog, author Alberto Raggi discusses the process of compiling a recently published review in The Journal of Headache and Pain. The review asks, in an era of a changing landscape in global population health, if improving the overall health of people suffering from headache disorders will be a feasible way to improve global population health.
European Headache Federation School of Advanced Studies
The European HeadacheFederation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.
The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.
Official journal of
-
-
-
The Journal of Headache and Pain is the official journal of the European Headache Federation, Lifting The Burden, and the Asian Regional Consortium for Headache.
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 7.3
5-year Journal Impact Factor: 7.7
Source Normalized Impact per Paper (SNIP): 1.830
SCImago Journal Rank (SJR): 1.791Speed 2023
Submission to first editorial decision (median days): 1
Submission to acceptance (median days): 44Usage 2023
Downloads: 3,022,321
Altmetric mentions: 3,296
- ISSN: 1129-2377 (electronic)
- ISSN: 1129-2369 (print)
Related reading
- Clinical Scales for Headache Disorders
- Headache Disorders in Pandemic Conditions
- Non-Migraine Primary Headaches in Medicine
- Migraine in Medicine
- Novel Synthetic Drugs in Migraine
- Monoclonal Antibodies in Headache
- Neurophysiology of the Migraine Brain
- Societal Impact of Headache
- Neuromodulation in Headache and Facial Pain Management
- Cluster Headache and other Trigeminal Autonomic Cephalgias
- Peripheral Interventional Management in Headache
- Placebos and Nocebos in Headaches
- Gender and Migraine
- Headache and Comorbidities in Childhood and Adolescence
- Comorbidities in Headache Disorders
- Pharmacological Management of Headaches
- Pathophysiology of Headaches